47.32
price down icon2.57%   -1.25
after-market Handel nachbörslich: 47.94 0.62 +1.31%
loading

Royalty Pharma Plc Aktie (RPRX) Neueste Nachrichten

pulisher
09:48 AM

Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year HighHere's What Happened - marketbeat.com

09:48 AM
pulisher
03:06 AM

Aberdeen Group plc Acquires 98,191 Shares of Royalty Pharma PLC $RPRX - marketbeat.com

03:06 AM
pulisher
Apr 05, 2026

Royalty Pharma plc (RPRX) stock price, news, quote and history - Yahoo Finance UK

Apr 05, 2026
pulisher
Apr 05, 2026

Can Royalty Pharma plc deliver consistent dividends2026 Outlook & Breakout Confirmation Trade Signals - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

RPRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026
pulisher
Apr 04, 2026

RPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026
pulisher
Apr 02, 2026

Royalty Pharma Plc Hits New 52-Week High at $48.74 - Markets Mojo

Apr 02, 2026
pulisher
Apr 02, 2026

Royalty Pharma (NASDAQ:RPRX) CFO Terrance Coyne Sells 34,791 Shares - marketbeat.com

Apr 02, 2026
pulisher
Apr 02, 2026

Royalty Pharma (RPRX) CFO-linked entities execute planned share sales - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Royalty Pharma plc (RPRX) latest stock news and headlines - Yahoo Finance Singapore

Apr 02, 2026
pulisher
Apr 02, 2026

RPRX Stock Price, Quote & Chart | ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX) - ChartMill

Apr 02, 2026
pulisher
Apr 01, 2026

Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal - Yahoo Finance UK

Apr 01, 2026
pulisher
Apr 01, 2026

Multiple RPRX Share Disposals by TPC RP Entities (RPRX) - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Pablo Legorreta: Pioneer of Pharmaceutical Royalties, Financial Innovator, and Founder and CEO of Royalty Pharma - BBN Times

Apr 01, 2026
pulisher
Apr 01, 2026

Zymeworks Appoints Kristin Stafford as Chief Financial Officer - The Manila Times

Apr 01, 2026
pulisher
Apr 01, 2026

J. Safra Sarasin Holding AG Purchases Shares of 90,035 Royalty Pharma PLC $RPRX - marketbeat.com

Apr 01, 2026
pulisher
Apr 01, 2026

Zymeworks Appoints Kristin Stafford as Chief Financial Officer - GlobeNewswire Inc.

Apr 01, 2026
pulisher
Apr 01, 2026

Trading the Move, Not the Narrative: (RPRX) Edition - Stock Traders Daily

Apr 01, 2026
pulisher
Apr 01, 2026

Royalty Pharma stock hits 52-week high at $47.87 By Investing.com - Investing.com Australia

Apr 01, 2026
pulisher
Mar 31, 2026

Royalty Pharma (NASDAQ:RPRX) Sets New 1-Year HighHere's What Happened - marketbeat.com

Mar 31, 2026
pulisher
Mar 31, 2026

Royalty Pharma (RPRX) director granted 815-share equity award - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Royalty Pharma stock hits 52-week high at $47.87 - Investing.com

Mar 31, 2026
pulisher
Mar 31, 2026

Denali Therapeutics scores $200 million shortly after first drug approval - The Business Journals

Mar 31, 2026
pulisher
Mar 31, 2026

TD Cowen reiterates Royalty Pharma stock Buy rating on lupus drug potential By Investing.com - Investing.com South Africa

Mar 31, 2026
pulisher
Mar 30, 2026

Royalty Pharma and J&J partner to develop autoimmune treatment - Yahoo Finance

Mar 30, 2026
pulisher
Mar 30, 2026

Royalty Pharma signs $500M co-development agreement with J&J - MSN

Mar 30, 2026
pulisher
Mar 30, 2026

Royalty Pharma in $500M R&D funding collaboration with J&J - MSN

Mar 30, 2026
pulisher
Mar 30, 2026

Royalty Pharma commits $500M to J&J autoimmune drug development By Investing.com - Investing.com Canada

Mar 30, 2026
pulisher
Mar 30, 2026

Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases - 富途牛牛

Mar 30, 2026
pulisher
Mar 30, 2026

Royalty Pharma commits $500M to J&J autoimmune drug development - Investing.com

Mar 30, 2026
pulisher
Mar 30, 2026

Johnson & Johnson taps Royalty Pharma for $500M autoimmune drug push - Stock Titan

Mar 30, 2026
pulisher
Mar 30, 2026

SG Americas Securities LLC Buys 234,629 Shares of Royalty Pharma PLC $RPRX - marketbeat.com

Mar 30, 2026
pulisher
Mar 30, 2026

Royalty Pharma PLC $RPRX Shares Sold by Cooper Investors PTY Ltd. - marketbeat.com

Mar 30, 2026
pulisher
Mar 29, 2026

Eastern Bank Acquires 263,867 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Mar 29, 2026
pulisher
Mar 28, 2026

Wedge Capital Management L L P NC Lowers Stock Position in Royalty Pharma PLC $RPRX - MarketBeat

Mar 28, 2026
pulisher
Mar 28, 2026

Wealth Enhancement Advisory Services LLC Buys 165,451 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Mar 28, 2026
pulisher
Mar 27, 2026

Royalty Pharma Refreshes Leadership As AI And Asia Shape Valuation Story - Yahoo Finance

Mar 27, 2026
pulisher
Mar 27, 2026

Royalty Pharma PLC (NASDAQ:RPRX) Given Average Rating of "Buy" by Analysts - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

Royalty Pharma PLC (NASDAQ:RPRX) Emerges as a Compelling Value Investment - ChartMill

Mar 27, 2026
pulisher
Mar 26, 2026

Morgan Stanley Maintains a Buy Rating on Royalty Pharma Plc (RPRX) With a $55 PT - MSN

Mar 26, 2026
pulisher
Mar 26, 2026

RPRX SEC FilingsRoyalty Pharma Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Royalty Pharma EVP Coyne sells shares worth $1.58 million By Investing.com - Investing.com Australia

Mar 26, 2026
pulisher
Mar 25, 2026

Insider Selling: Royalty Pharma (NASDAQ:RPRX) CFO Sells 34,791 Shares of Stock - MarketBeat

Mar 25, 2026
pulisher
Mar 25, 2026

Royalty Pharma EVP Coyne sells shares worth $1.58 million - Investing.com

Mar 25, 2026
pulisher
Mar 25, 2026

Royalty Pharma (RPRX) CFO’s entities sell 34,791 shares under 10b5-1 plan - Stock Titan

Mar 25, 2026
pulisher
Mar 25, 2026

Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance

Mar 25, 2026
pulisher
Mar 24, 2026

Nordea Investment Management AB Grows Position in Royalty Pharma PLC $RPRX - MarketBeat

Mar 24, 2026
pulisher
Mar 24, 2026

Royalty Pharma names Lucas Glass as head of artificial intelligence By Investing.com - Investing.com India

Mar 24, 2026
pulisher
Mar 23, 2026

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks - Yahoo Finance UK

Mar 23, 2026
pulisher
Mar 23, 2026

Affiliates of RPRX sell multiple blocks of common stock (RPRX) - Stock Titan

Mar 23, 2026
$27.88
price down icon 1.59%
$48.77
price down icon 0.87%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):